Alphabet's Isomorphic Labs in talks to raise at $40B+ valuation

Isomorphic Labs, the AI drug discovery startup spun out of Alphabet's Google DeepMind, is in early talks to raise new funding at a valuation of at least $40 billion, according to people familiar with the matter. The size of the round was not disclosed.

• Isomorphic Labs was spun out of Alphabet's Google DeepMind
• Talks value the company at no less than $40 billion
• The funding discussions are at an early stage